Search research articles
Contact Us
Filters
Showing results (71-80 of 281) with videos related to
Page
of 29
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
April 20, 2010
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
Stefano Barbi, Ivana Cataldo, Giovanni De Manzoni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2004
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells
Manu Kohli, Jian Yu, Craig Seaman, et al.
Cancer Research
|
December 3, 2005
Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer
Milo Frattini, Stefano Signoroni, Silvana Pilotti, et al.
Oncogene
|
May 16, 2023
Correction: Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
Kyle Knickelbein, Jingshan Tong, Dongshi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2024
How to Test <i>HER2</i> for Predicting Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer? Evidence From the Secondary Analysis of Biomarkers of CALGB/SWOG 80405
Andrea Sartore-Bianchi, Silvia Marsoni, Alessio Amatu, et al.
Cancer Letters
|
January 2, 2017
Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members
Annalisa Conti, Maria Teresa Majorini, Enrico Fontanella, et al.
Cancer Research
|
March 17, 2007
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Nature Reviews. Clinical Oncology
|
April 17, 2021
Precision oncology in metastatic colorectal cancer - from biology to medicine
Federica Di Nicolantonio, Pietro Paolo Vitiello, Silvia Marsoni, et al.
EMBO Molecular Medicine
|
January 20, 2017
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions
Gabriele Picco, Consalvo Petti, Alessia Centonze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET
Cristina Basilico, Selma Pennacchietti, Elisa Vigna, et al.
Page
of 29
Search research articles
Search
Showing results (71-80 of 281) with videos related to
Sort By:
Page
of 29
Journal of Experimental & Clinical Cancer Research : CR
|
April 20, 2010
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
Stefano Barbi, Ivana Cataldo, Giovanni De Manzoni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2004
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells
Manu Kohli, Jian Yu, Craig Seaman, et al.
Cancer Research
|
December 3, 2005
Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer
Milo Frattini, Stefano Signoroni, Silvana Pilotti, et al.
Oncogene
|
May 16, 2023
Correction: Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
Kyle Knickelbein, Jingshan Tong, Dongshi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2024
How to Test <i>HER2</i> for Predicting Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer? Evidence From the Secondary Analysis of Biomarkers of CALGB/SWOG 80405
Andrea Sartore-Bianchi, Silvia Marsoni, Alessio Amatu, et al.
Cancer Letters
|
January 2, 2017
Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members
Annalisa Conti, Maria Teresa Majorini, Enrico Fontanella, et al.
Cancer Research
|
March 17, 2007
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Nature Reviews. Clinical Oncology
|
April 17, 2021
Precision oncology in metastatic colorectal cancer - from biology to medicine
Federica Di Nicolantonio, Pietro Paolo Vitiello, Silvia Marsoni, et al.
EMBO Molecular Medicine
|
January 20, 2017
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions
Gabriele Picco, Consalvo Petti, Alessia Centonze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2013
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET
Cristina Basilico, Selma Pennacchietti, Elisa Vigna, et al.
Page
of 29